ஜியோர்டானோ பாட்டில் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜியோர்டானோ பாட்டில். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜியோர்டானோ பாட்டில் Today - Breaking & Trending Today

Allelica Raises $1.75 Million in Seed Financing to Advance Polygenic Risk Score (PRS) Analysis into Clinical Practice

(1)
PRS stratifies disease risk and brings precision medicine into clinical routine
Allelica, a leading genomics software company specialising in developing polygenic risk scores (PRSs) for common diseases, today announced that the company has raised $1.75 million in a seed financing round led by Valor Ventures, Sternberg Health, Pi Campus, as well as strategic business angels also participated in the round. As part of the transaction, Valor Ventures General Partner Gary Peat has joined the Allelica board of directors and Allelica has relocated its headquarters to New York City.
The proceeds of the financing will be used to advance clinical integration of Allelica s PRS software into healthcare systems in the US. A PRS is a measurement of a person s risk of disease based on their genes and is based on combining the effects of a large number of genetic variants across the genome. This information can be used to stratify individuals based on their risk of disease. By co ....

New York , United States , Giordano Bott , Kostenloser Wertpapierhandel , Mike Sinclair , Sternberg Health , Valor Ventures , Valor Ventures General Partner Gary Peat , Gary Peat , General Partner , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஜியோர்டானோ பாட்டில் , மைக் சின்க்ளேர் , ஸ்டென்பெர்க் ஆரோக்கியம் , வீரம் முயற்சிகள் , வீரம் முயற்சிகள் ஜநரல் கூட்டாளர் கேரி கரி , கேரி கரி , ஜநரல் கூட்டாளர் ,

Allelica's polygenic risk score data published in i Circulation /i

Allelica s polygenic risk score data published in
Circulation
Halsin Partners
E-Mail
Rome, Italy, March 8, 2021 - Allelica, a leading genomics software company specialising in developing polygenic risk scores (PRS) for personalised medicine, today announced publication of a study in
Circulation (Vol. 143, Issue 10) showing that the effect of LDL cholesterol on a person s risk of having a heart attack depends on their genes. Using Allelica s proprietary PRS analysis software, the data showed that combining information on an individual s genetic risk of heart attack with their LDL level helps determine those at most risk from heart attack, including those potentially in need of treatment with statins or PCSK9 inhibitors. The PRS was also able to identify individuals eligible for therapeutic intervention based on current guidelines, which do not include polygenic risk, but who are in fact at low risk of heart attack based on their genes and ....

Giordano Bott , George Busby , Coronary Artery Disease , United Kingdom , Medicine Health , Health Care Systems Services , Health Professionals , ஜியோர்டானோ பாட்டில் , ஜார்ஜ் பஸ்பி , கரோனரி தமனி நோய் , ஒன்றுபட்டது கிஂக்டம் , மருந்து ஆரோக்கியம் , ஆரோக்கியம் பராமரிப்பு அமைப்புகள் சேவைகள் , ஆரோக்கியம் ப்ரொஃபெஶநல்ஸ் ,

Allelica's polygenic risk score data published in Circulation

Allelica's polygenic risk score data published in Circulation
sciencecodex.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencecodex.com Daily Mail and Mail on Sunday newspapers.

Giordano Bott , George Busby , Coronary Artery Disease , United Kingdom , ஜியோர்டானோ பாட்டில் , ஜார்ஜ் பஸ்பி , கரோனரி தமனி நோய் , ஒன்றுபட்டது கிஂக்டம் ,

Interaction between LDL cholesterol and PRS can predict risk of heart attack

Interaction between LDL cholesterol and PRS can predict risk of heart attack
Allelica, a leading genomics software company specializing in developing polygenic risk scores (PRS) for personalized medicine, today announced publication of a study in
Circulation (Vol. 143, Issue 10) showing that the effect of LDL cholesterol on a person s risk of having a heart attack depends on their genes.
Using Allelica s proprietary PRS analysis software, the data showed that combining information on an individual s genetic risk of heart attack with their LDL level helps determine those at most risk from heart attack, including those potentially in need of treatment with statins or PCSK9 inhibitors. ....

Giordano Bott , George Busby , Emily Henderson , Coronary Artery Disease , United Kingdom , Heart Attack , ஜியோர்டானோ பாட்டில் , ஜார்ஜ் பஸ்பி , எமிலி ஹென்டர்சன் , கரோனரி தமனி நோய் , ஒன்றுபட்டது கிஂக்டம் , இதயம் தாக்குதல் ,

Allelica's polygenic risk score data published in <i>Circulation</i>

Allelica's polygenic risk score data published in Circulation
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

Giordano Bott , George Busby , Coronary Artery Disease , United Kingdom , ஜியோர்டானோ பாட்டில் , ஜார்ஜ் பஸ்பி , கரோனரி தமனி நோய் , ஒன்றுபட்டது கிஂக்டம் ,